Synapse - GDMT, Medicine

Search Within

GDMT, Medicine

Results (314)

A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)

Meeting Abstract

Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
Breast Cancer Research and Treatment (2006)

Fulltext@MSK | Save

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer

Journal Article

Sabbatini, P.; Dupont, J.; Aghajanian, C.; Derosa, F.; Poynor, E.; Anderson, S.; Hensley, M.; Livingston, P.; Iasonos, A.; Spriggs, D.; more...
Clinical Cancer Research (2006)

Fulltext@MSK | Save

Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning

Journal Article

Hensley, M. L.; Correa, D. D.; Thaler, H.; Wilton, A.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Spriggs, D.; Aghajanian, C.
Gynecologic Oncology (2006)

Fulltext@MSK | Save

Topotecan and liposomal doxorubicin in recurrent ovarian cancer: Is sequence important?

Journal Article

Dupont, J.; Aghajanian, C.; Andrea, G.; Lovegren, M.; Chuai, S.; Venkatraman, E.; Hensley, M.; Anderson, S.; Spriggs, D.; Sabbatini, P.
International Journal of Gynecological Cancer (2006)

Fulltext@MSK | Save

Lysophosphatidic acid acyltransferase-β (LPAAT-β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

Journal Article

Diefenbach, C. S. M.; Soslow, R. A.; Iasonos, A.; Linkov, I.; Hedvat, C.; Bonham, L.; Singer, J.; Barakat, R. R.; Aghajanian, C.; Dupont, J.
Cancer (2006)

Fulltext@MSK | Save

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

Journal Article

Chi, D. S.; McCaughty, K.; Diaz, J. P.; Huh, J.; Schwabenbauer, S.; Hummer, A. J.; Venkatraman, E. S.; Aghajanian, C.; Sonoda, Y.; Abu-Rustum, N. R.; more...
Cancer (2006)

Fulltext@MSK | Save

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center

Journal Article

Abu-Rustum, N. R.; Alektiar, K.; Iasonos, A.; Lev, G.; Sonoda, Y.; Aghajanian, C.; Chi, D. S.; Barakat, R. R.
Gynecologic Oncology (2006)

Fulltext@MSK | Save

Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatinirinotecan and radiotherapy

Meeting Abstract

Tew, W. P.; Minsky, B.; Bains, M.; Rizk, N.; Rusch, V.; Kelsen, D. P.; Shah, M.; Kepler, S.; Gonen, M.; Ilson, D. H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Paclitaxel, carboplatin plus gemcitabine (PCG) as first-line treatment for advanced epithelial ovarian cancer (EOC): Pathologic complete response (pCR) and impact on cognitive functioning

Meeting Abstract

Hensley, M. L.; Correa, D.; Thaler, H.; Wilton, A.; Venkatraman, E.; Sabbatini, P.; Chi, D.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible

Meeting Abstract

Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save